VCLS
LIVE

Serial Number

79408547

Owner

VOISIN CONSULTING LIFE SCIENCES

Attorney

Lindsay M.R. Jones

Filing Date

Aug 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VCLS Trademark

Serial Number: 79408547

VCLS is a trademark filed by VOISIN CONSULTING LIFE SCIENCES on August 20, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

VOISIN CONSULTING LIFE SCIENCES (2 trademarks)

64 Avenue Pierre Grenier

Entity Type: 99

Trademark Details

Filing Date

August 20, 2024

Registration Date

Not Registered

Published for Opposition

May 19, 2026

Goods & Services

Commercial consulting concerning the business development and marketing of cosmetic products, pharmaceuticals, nutraceuticals, medicines, food supplements, and medical apparatus and devices; conducting market studies; advice regarding public relations communication strategies relating to cosmetic, pharmaceutical, and nutraceutical products, medication, food supplements, and medical devices and apparatus, namely, public relations and media relations; setting up communication tools, namely, providing public relations and media relations in the context of the commercial introduction of cosmetic products, pharmaceuticals, nutraceuticals, medicine, food supplements, and medical apparatus and devices; commercial advice in the nature of business advice relating to the import and export of cosmetic products, pharmaceuticals, nutraceuticals, medicines, food supplements, and medical apparatus and devices

Providing scientific research and technology research services in the field of developing pharmaceuticals, nutraceuticals, cosmetic products, medicine, food supplements, and medical apparatus and devices; technical project studies in the nature of conducting scientific and technological feasibility studies in the field of development of pharmaceutical, nutraceutical, and cosmetic products, medicine, food supplements, and medical apparatus and devices; technical and scientific assistance, namely, technical writing for others of user instructions for pharmaceutical, nutraceutical, and cosmetic products, medicine, food supplements, and medical apparatus and devices; providing scientific research information in the nature of data and results from scientific, pharmaceutical, clinical, biological, and medical research and development from an online searchable database; conducting scientific, pharmaceutical, clinical trial, biological, and medical research services using databases; hosting the software of others for the provision of information, results, and data relating to scientific, pharmaceutical, clinical, biological, and medical research and development; design of software and database systems for the provision of information, results, and data relating to scientific, pharmaceutical, clinical, biological, and medical research and development; installation of software for the provision of information, results, and data relating to the scientific, pharmaceutical, clinical, biological, and medical research and development; updating and maintenance of software and database systems for the provision of information, results, and data relating to scientific, pharmaceutical, clinical, biological, and medical research and development; computer services, namely, providing electronic storage of data with respect to scientific, pharmaceutical, clinical, biological, and medical research and development; providing temporary use of online non-downloadable computer software for analysing data in the fields of scientific, pharmaceutical, clinical, biological, and medical research and development; providing internet search engines in the field of scientific, pharmaceutical, clinical, biological, and medical data and information; computer technology consultancy services with respect to computer database programs and systems relating to the provision of information, results, and data with respect to scientific, pharmaceutical, clinical, biological, and medical research and development

Regulatory compliance consulting and legal advice, all in the field of development, implementation, and marketing of pharmaceutical, nutraceutical, and cosmetic products, medicine, food supplements, and medical apparatus and devices; regulatory compliance consulting and legal advice, all in the field of drawing up user instructions for pharmaceutical, nutraceutical, and cosmetic products, medicine, food supplements, and medical apparatus and devices; legal information and legal advice for obtaining legal authorizations for marketing of pharmaceutical, nutraceutical, and cosmetic products, medicine, food supplements, and medical apparatus and devices

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 24, 2026 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 16, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 29, 2026 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 5, 2025 GNFN
FINAL REFUSAL E-MAILED
Nov 5, 2025 GNFR
FINAL REFUSAL WRITTEN
Nov 5, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2025 TROA
REFUSAL PROCESSED BY IB
Apr 19, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 3, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 3, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 28, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 27, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 25, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 4, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 31, 2024 REPR